(Q41863035)

13 October 2017

Monotherapy with labetalol for hypertensive patients with normal and impaired renal function (English)

1 reference

13 October 2017

Thompson FD

1

1 reference

13 October 2017

Joekes AM

series ordinal

2

1 reference

13 October 2017

Hussein MM

series ordinal

3

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 January 1979

1 reference

British Journal of Clinical Pharmacology

13 October 2017

1 reference

13 October 2017

8

1 reference

13 October 2017

Suppl 2

1 reference

13 October 2017

129S-133S

1 reference

Metabolism of labetalol by animals and man.

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1429748

PubMed Central

reference URL

Treatment of hypertensive emergencies with oral labetalol

5 June 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/526392

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/526392

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

13 October 2017

PubMed publication ID

526392

1 reference